Multiple sclerosis progression: time for a new mechanism-driven frameworkTanja Kuhlmann, Emmaunelle Waubant, Marcello Moccia et al.|The Lancet Neurology|2022Cited by 624
Recommendations from the national multiple sclerosis society clinical outcomes assessment task forceRichard A. Rudick, Ernest Willoughby, Jack P. Antel et al.|Annals of Neurology|1997Cited by 368
Clinical outcomes assessment in multiple sclerosisRichard A. Rudick, Ernest Willoughby, Jill S. Fischer et al.|Annals of Neurology|1996Cited by 177
Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disordersOlga Ciccarelli, Daniel H. Reich, Claudia Chien et al.|The Lancet Neurology|2019Cited by 169
Cell-based therapeutic strategies for multiple sclerosisNeil Scolding, Stefano Pluchino, Marcelo C. Pasquini et al.|Brain|2017Cited by 169